Publicaciones en las que colabora con MARIO PÉREZ DIEGO (9)

2023

  1. Cannabinoid WIN55,212-2 reprograms monocytes and macrophages to inhibit LPS-induced inflammation

    Frontiers in Immunology, Vol. 14

2022

  1. Allergoid-mannan conjugates imprint tolerogenic features in human macrophages

    Allergy: European Journal of Allergy and Clinical Immunology

  2. Allergoid–mannan conjugates reprogram monocytes into tolerogenic dendritic cells via epigenetic and metabolic rewiring

    Journal of Allergy and Clinical Immunology, Vol. 149, Núm. 1, pp. 212-222.e9

  3. Cannabinoid WIN55212-2 impairs peanut-allergic sensitization and promotes the generation of allergen-specific regulatory T cells

    Clinical and Experimental Allergy, Vol. 52, Núm. 4, pp. 540-549

  4. Cannabinoids induce functional Tregs by promoting tolerogenic DCs via autophagy and metabolic reprograming

    Mucosal Immunology, Vol. 15, Núm. 1, pp. 96-108

  5. The cannabinoid WIN55212-2 suppresses effector T-cell responses and promotes regulatory T cells in human tonsils

    Allergy: European Journal of Allergy and Clinical Immunology

2021

  1. The cannabinoid WIN55212-2 restores rhinovirus-induced epithelial barrier disruption

    Allergy: European Journal of Allergy and Clinical Immunology

2020

  1. Alum impairs tolerogenic properties induced by allergoid-mannan conjugates inhibiting mTOR and metabolic reprogramming in human DCs

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 75, Núm. 3, pp. 648-659

  2. The Role of Cannabinoids in Allergic Diseases: Collegium Internationale Allergologicum (CIA) Update 2020

    International Archives of Allergy and Immunology, Vol. 181, Núm. 8, pp. 565-584